铯-131前列腺近距离放疗后长期生活质量
本研究评估了接受铯-131前列腺近距离放疗至少4年后的前列腺癌患者报告的生活质量(QOL)评分。在中位随访5.5年时,EPIC和AUA评分较基线无临床显著变化,但EPIC尿失禁子评分有统计学恶化。接受外照射放疗或α受体阻滞剂治疗的患者QOL结局改善,而雄激素剥夺治疗与QOL变化无关。
要点
- 铯-131近距离放疗后中位5.5年,尿路和肠道QOL较基线无临床显著变化。
- EPIC尿失禁子评分出现统计学恶化,但无临床显著意义。
- 外照射放疗或α受体阻滞剂治疗与更好的QOL结局相关。
核心结论
- 铯-131前列腺近距离放疗后长期尿路或肠道患者报告QOL变化极小,患者能够恢复并长期维持基线QOL。
研究设计与样本
- 单中心回顾性研究,纳入290例接受铯-131前列腺近距离放疗超过4年的前列腺癌患者,治疗前及每次随访填写EPIC QOL问卷和AUASS调查,采用Wilcoxon符号秩检验比较基线与此后至少4年最后随访的评分。
主要发现
- 在中位最后随访5.5年时,EPIC或AUA评分较基线无临床显著变化。
- EPIC尿失禁子评分出现统计学恶化。
- 亚组分析显示接受外照射放疗或α受体阻滞剂治疗的患者QOL结局改善,而雄激素剥夺治疗与QOL变化无关。
临床怎么用
- 铯-131前列腺近距离放疗后长期QOL总体稳定,但需关注尿失禁子评分的统计学恶化。
- 对于接受外照射放疗或α受体阻滞剂治疗的患者,可能观察到更好的QOL结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate long-term patient-reported quality of life (QOL) scores in men with prostate cancer treated at our institution with 131Cs prostate brachytherapy. METHODS AND MATERIALS: Patients treated more than 4 years ago with 131Cs (n=290) were asked to fill out an Expanded Prostate Cancer Index Composite (EPIC) QOL questionnaire and American Urological Association Symptom Score (AUASS) survey, before treatment and at each follow-up appointment. We compared patients' EPIC and AUA scores at baseline with scores at a last follow-up of at least 4 years after treatment using the Wilcoxon signed-rank test. RESULTS: At a median last follow-up of 5.5 years after treatment with 131Cs prostate brachytherapy there were no clinically significant changes in the EPIC or AUA scores from baseline. There was statistical worsening in the EPIC urinary incontinence subscore. Subset analyses revealed improved QOL outcomes in patients who received external beam radiation therapy or α-blocker therapy, whereas androgen deprivation therapy was not associated with differences in QOL change. CONCLUSIONS: Our results demonstrate minimal long-term changes in urinary or bowel patient-reported QOL with 131Cs prostate brachytherapy. These findings suggest that patients treated with this isotope are able to recover and then maintain their baseline QOL in the long term.
引用
- Glaser SM, Chen KS, Benoit RM, et al. Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131. Int J Radiat Oncol Biol Phys. 2017. PMID: 28721888. doi:10.1016/j.ijrobp.2017.03.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。